Section one: Contracting authority
one.1) Name and addresses
NHS Blood & Transplant
North Bristol Park
Filton, Bristol
BS34 7QH
marta.drozdzowska@nhsbt.nhs.uk
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems
Reference number
NHSBT1249
two.1.2) Main CPV code
- 38434540 - Biomedical equipment
two.1.3) Type of contract
Supplies
two.1.4) Short description
Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas:
- Solid organ transplantation and clinical advice for donor selection
- Haematopoietic stem cell transplantation and clinical advice for donor selection
- Blood transfusion and transfusion reactions (SHOT)
- Platelet refractoriness and provision of HLA/ HPA selected components
- Platelet immunology
- Granulocyte immunology
- Immunogenetics including diagnostic testing and pharmacogenetics
- Haematopoietic stem cell donor registry typing
NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement.
The Framework Agreement was awarded for 4 years and divided into lots as follows:
Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor
Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
two.1.6) Information about lots
This contract is divided into lots: Yes
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £7,143,000
two.2) Description
two.2.1) Title
HLA Antibody Detection and Definition Systems
Lot No
1
two.2.2) Additional CPV code(s)
- 33100000 - Medical equipments
- 33140000 - Medical consumables
- 33141625 - Diagnostic kits
- 38434540 - Biomedical equipment
- 50421000 - Repair and maintenance services of medical equipment
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas:
- Solid organ transplantation and clinical advice for donor selection
- Haematopoietic stem cell transplantation and clinical advice for donor selection
- Blood transfusion and transfusion reactions (SHOT)
- Platelet refractoriness and provision of HLA/ HPA selected components
- Platelet immunology
- Granulocyte immunology
- Immunogenetics including diagnostic testing and pharmacogenetics
- Haematopoietic stem cell donor registry typing
NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement.
The Framework Agreement was awarded for 4 years and divided into lots as follows:
Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor
Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Maintenance of Existing Luminex Systems
Lot No
2
two.2.2) Additional CPV code(s)
- 50421000 - Repair and maintenance services of medical equipment
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas:
- Solid organ transplantation and clinical advice for donor selection
- Haematopoietic stem cell transplantation and clinical advice for donor selection
- Blood transfusion and transfusion reactions (SHOT)
- Platelet refractoriness and provision of HLA/ HPA selected components
- Platelet immunology
- Granulocyte immunology
- Immunogenetics including diagnostic testing and pharmacogenetics
- Haematopoietic stem cell donor registry typing
NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve.
For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement.
The Framework Agreement was awarded for 4 years and divided into lots as follows:
Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor
Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2019/S 231-565906
Section five. Award of contract
Contract No
NHSBT1249
Lot No
1
Title
HLA Antibody Detection and Definition Systems
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
22 February 2021
five.2.2) Information about tenders
Number of tenders received: 3
The contract has been awarded to a group of economic operators: Yes
five.2.3) Name and address of the contractor
Immucor
Solihull
Country
United Kingdom
NUTS code
- UK - UNITED KINGDOM
The contractor is an SME
Yes
five.2.3) Name and address of the contractor
VH Bio Ltd
Gateshead
Country
United Kingdom
NUTS code
- UK - UNITED KINGDOM
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £7,020,000
Section five. Award of contract
Contract No
NHSBT1249
Lot No
2
Title
Maintenance of Existing Luminex Systems
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
1 March 2021
five.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Immucor
Solihull
Country
United Kingdom
NUTS code
- UK - UNITED KINGDOM
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £123,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
NHS Blood and Transplant
Bristol
Country
United Kingdom